Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Eledon Pharmaceuticals Inc (NASDAQ: ELDN) closed at $1.65 in the last session, up 1.85% from day before closing price of $1.62. In other words, the price has increased by $1.85 from its previous closing price. On the day, 1.17 million shares were traded. ELDN stock price reached its highest trading level at $1.67 during the session, while it also had its lowest trading level at $1.575.
Ratios:
We take a closer look at ELDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 6.74. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 123806536 and an Enterprise Value of 6209150.
Stock Price History:
The Beta on a monthly basis for ELDN is 0.89, which has changed by -0.6407982 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, ELDN has reached a high of $4.98, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is -23.74%, while the 200-Day Moving Average is calculated to be -40.65%.
Shares Statistics:
According to the various share statistics, ELDN traded on average about 2.17M shares per day over the past 3-months and 863390 shares per day over the past 10 days. A total of 75.08M shares are outstanding, with a floating share count of 70.02M. Insiders hold about 6.75% of the company’s shares, while institutions hold 49.91% stake in the company. Shares short for ELDN as of 1765756800 were 5656993 with a Short Ratio of 2.61, compared to 1763078400 on 5001990. Therefore, it implies a Short% of Shares Outstanding of 5656993 and a Short% of Float of 8.229999000000001.
Earnings Estimates
. The current market rating for Eledon Pharmaceuticals Inc (ELDN) reflects the collective analysis of 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.17 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$0.59 and -$0.7 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.95, with 4.0 analysts recommending between -$0.72 and -$1.31.
